N/A
Completed N=43
Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)
Huntington Disease · Parkinson's Disease
Source: ClinicalTrials.gov NCT05126862 ↗
Enrolled (actual)
43
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcomePrimary: Proportion of Participants Completing at Least 50% of the MindTrails Sessions — 14; 14 Participants
Summary
The purpose of this study is conduct a pilot open trial of a web-based cognitive bias modification intervention to reduce anxiety symptoms in persons with Huntington's disease and persons with Parkinson's disease.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Proportion of Participants Completing at Least 50% of the MindTrails Sessions |
14; 14 | — |
| PRIMARY Participant Perceptions of Perceived Benefits and Limitations of MindTrails |
12; 9; 1; 1; 3; 1 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of Huntington's disease or Parkinson's disease
- Age 21 or older
- Has anxiety symptoms (NeuroQoL Anxiety short form >12)
Exclusion Criteria
- Unable to read and understand English
- Previously diagnosed with dementia
- Not located in the USA
Data sourced from ClinicalTrials.gov (NCT05126862). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.